Yale Catriona

Insider Buys Quantity –
0
2024-06-11SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
2,825
0.0039%
$22.64$63,961+0.3%
2024-03-13SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
723
0.0011%
$28.33$20,483-22.13%
2024-03-04SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
20,646
0.0413%
$35.49$732,727-29.35%
2023-12-14SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
597
0.001%
$20.76$12,394-1.45%
2023-09-21SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
5,000
0.0089%
$48.07$240,356-55.16%
2023-09-13SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
617
0.0011%
$50.34$31,060-56.72%
2023-08-28SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
5,745
0.0103%
$49.99$287,191-56.03%
2023-06-23SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
11,000
0.0234%
$50.76$558,360-54.81%
2023-06-22SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
11,000
0.0235%
$52.18$573,935-55.82%
2023-06-21SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
11,349
0.024%
$52.26$593,095-56.39%
2023-06-13SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
591
0.0012%
$55.16$32,600-59.3%
2023-01-13SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
5,000
0.0107%
$50.53$252,651-11.25%
2023-01-13SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
1,048
0.0022%
$49.12$51,476-11.25%
2022-12-12SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
5,000
0.0107%
$43.23$216,137+4.07%
2022-11-10SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
5,000
0.0107%
$39.42$197,105+13.94%
2022-10-10SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
5,000
0.0108%
$37.99$189,950+19.19%
2021-10-15SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
12,500
0.0362%
$21.59$269,826-29.33%
2021-09-15SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
12,500
0.0361%
$24.69$308,605-38.1%
2021-08-16SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
10,000
0.0286%
$18.79$187,900-5.6%
2021-07-15SaleAkero Therapeutics, Inc.
AKRO
Chief Development Officer
10,000
0.0271%
$20.90$209,044-10.03%